PCRX Pacira BioSciences, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 4, 2026
$25,21
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$18,80rendah 52m
$27,66tinggi 52m
Kapitalisasi Pasar (MRQ)
$1.00B
P/E (TTM)
70.0
EPS (TTM)
$0.36
Pendapatan (TTM)
$746M
lencana Anda
Rentang 52M
$19–$28
Peringkat Analis
BUY
Target Harga
$30
P/E
70.0
ROE
2.0%
Margin Laba Bersih
2.0%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
PCRX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$25.21
Kapitalisasi Pasar (MRQ)
$1.00B
P/E (TTM)
70.0
EPS (TTM)
$0.36
Pendapatan (TTM)
$746M
ROE (TTM)
2.0%
D/E Utang/Ekuitas (MRQ)
0.5
Rentang 52M
$19–$28
PCRX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$726M2016-12-31 → 2025-12-31
EPS$0.162016-12-31 → 2025-12-31
Arus Kas Bebas$137M2016-12-31 → 2025-12-31
Margin bersih2.0%2016-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | PCRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | 70.0rata-rata 5T ≈74.0 | ≈74.0 | · | · | |
| P/S (TTM) | 1.3rata-rata 5T ≈2.5 | ≈2.5 | · | · | |
| P/B (MRQ) | 1.5rata-rata 5T ≈2.1 | ≈2.1 | 3.7 | Kurang nilai | |
| EV / EBITDA (TTM) | 10.6 | · | · | · | |
| Harga / FCF (TTM) | 5.6rata-rata 5T ≈14.6 | ≈14.6 | · | · | |
| Harga / Arus Kas (TTM) | 5.3rata-rata 5T ≈11.1 | ≈11.1 | · | · | |
| EV / Pendapatan (TTM) | 1.5 | · | · | · | |
| EV / FCF (TTM) | 6.2 | · | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | 2.6rata-rata 5T ≈9.5 | ≈9.5 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | PCRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | 2.7%rata-rata 5T ≈10.3% | ≈10.3% | -2342.9% | Tingkat teratas | |
| Margin EBITDA (TTM) | 14.1%rata-rata 5T ≈21.0% | ≈21.0% | -1487.9% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | 2.4%rata-rata 5T ≈6.0% | ≈6.0% | -414.1% | Tingkat teratas | |
| Margin Laba Bersih (TTM) | 2.0%rata-rata 5T ≈4.3% | ≈4.3% | -1320.1% | Tingkat teratas | |
| ROA (TTM) | 1.1%rata-rata 5T ≈0.01% | ≈0.01% | -34.1% | Tingkat teratas | |
| ROE (TTM) | 2.0%rata-rata 5T ≈0.14% | ≈0.14% | -39.7% | Tingkat teratas | |
| ROIC | 0.75%rata-rata 5T ≈2.2% | ≈2.2% | -30.5% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | PCRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.5 | · | 0.3 | Utang tinggi | |
| Rasio Lancar (MRQ) | 5.0rata-rata 5T ≈3.4 | ≈3.4 | 10.1 | Likuiditas rendah | |
| Rasio Cepat (MRQ) | 3.1rata-rata 5T ≈2.6 | ≈2.6 | 9.0 | Likuiditas rendah | |
| Utang Jangka Panjang / Ekuitas (MRQ) | 0.5 | · | 0.3 | Utang tinggi |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | PCRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 3.6%rata-rata 5T ≈11.6% | ≈11.6% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 2.9%rata-rata 5T ≈9.4% | ≈9.4% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 11.1% | · | · | · | |
| EPS YoY | 161.8%rata-rata 5T ≈8.8% | ≈8.8% | · | · | |
| Net Income YoY (Laba Bersih YoY) | 163.7%rata-rata 5T ≈10.2% | ≈10.2% | · | · | |
| EPS CAGR 3Y (CAGR EPS 3T) | -22.2% | · | · | · | |
| EPS CAGR 5Y (CAGR EPS 5T) | -45.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR Laba Bersih 3T) | -23.8% | · | · | · | |
| Net Income CAGR 5Y (CAGR Laba Bersih 5T) | -45.4% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | PCRX | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.5rata-rata 5T ≈0.4 | ≈0.4 | 0.2 | Tingkat teratas | |
| Inventory Turnover (Perputaran Persediaan) | 1.1rata-rata 5T ≈1.6 | ≈1.6 | · | · | |
| Receivables Turnover (Perputaran Piutang) | 6.1rata-rata 5T ≈6.7 | ≈6.7 | 11.6 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$880.5K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-2.3%
Laporan Berikutnya
Nov 04, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 3, 2026 | $0.73 | $0.66 | 10.6% |
| 31 Maret 2026 | Mei 6, 2026 | $0.60 | $0.57 | 4.4% |
| 31 Des. 2025 | $0.57 | $0.92 | -38.2% | |
| 30 Sep. 2025 | $0.70 | $0.66 | 5.3% | |
| 30 Juni 2025 | $0.74 | $0.72 | 2.1% | |
| 31 Maret 2025 | $0.62 | $0.61 | 2.0% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Cost of Revenue | $150M | $170M | $185M | $199M | $140M | $117M | $107M | $87M | $88M | $110M | $72M | $77M | |
| R&D Expense | $117M | $82M | $76M | $85M | $56M | $59M | $72M | $56M | $57M | $46M | $29M | $19M | |
| SG&A Expense | $369M | $294M | $269M | $255M | $199M | $194M | $201M | $177M | $161M | $153M | $139M | $107M | |
| Operating Expenses | $707M | $774M | $587M | $607M | $452M | $383M | $411M | $321M | $312M | $308M | $240M | $203M | |
| Operating Income | $19M | $-73M | $88M | $60M | $90M | $46M | $10M | $16M | $-25M | $-32M | $9M | $-5M | |
| Interest Expense | · | · | $20M | $40M | $32M | $26M | $24M | $22M | $18M | $7M | $8M | $8M | |
| Interest Income | $23M | $20M | $11M | $5M | $896.0K | $5M | $7M | $6M | $4M | $1M | $678.0K | $382.0K | |
| Other Non-op | $-7M | $-373.0K | $-186.0K | $-11M | $-3M | $3M | $-5M | $-888.0K | $167.0K | $-82.0K | $-165.0K | $-159.0K | |
| Pretax Income | $17M | $-63M | $62M | $13M | $56M | $20M | $-11M | $-425.0K | $-42M | $-38M | $2M | $-14M | |
| Income Tax | $10M | $36M | $20M | $-3M | $14M | $-125M | $268.0K | $46.0K | $140.0K | $105.0K | $264.0K | $173.0K | |
| Net Income | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| EPS (Basic) | $0.16 | $-2.15 | $0.91 | $0.35 | $0.95 | $3.41 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.05 | $-0.39 | |
| EPS (Diluted) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 | |
| Shares (Basic) | 44,566,000 | 46,245,000 | 46,222,000 | 45,521,000 | 44,262,000 | 42,671,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 36,540,000 | 35,299,000 | |
| Shares (Diluted) | 45,042,000 | 46,245,000 | 51,979,000 | 46,538,000 | 45,630,000 | 43,682,000 | 41,513,000 | 40,911,000 | 39,806,000 | 37,236,000 | 41,301,000 | 35,299,000 | |
| EBITDA | $110M | $5M | $163M | $152M | $118M | $66M | $30M | $29M | $-11M | $-19M | $21M | $5M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159M | $277M | $153M | $104M | $586M | $100M | $78M | $133M | $54M | $36M | $54M | $38M | |
| Short-term Investments | $80M | $208M | $125M | $185M | $71M | $422M | $214M | $251M | $257M | $137M | $102M | $119M | |
| Receivables | $124M | $113M | $106M | $98M | $96M | $53M | $48M | $38M | $32M | $30M | $26M | $22M | |
| Inventory | $153M | $125M | $104M | $96M | $99M | $65M | $58M | $49M | $41M | $31M | $62M | $29M | |
| Prepaid Expense | $33M | $22M | $22M | $15M | $15M | $12M | $11M | $8M | $7M | $9M | $6M | $4M | |
| Current Assets | $548M | $745M | $510M | $498M | $866M | $652M | $409M | $478M | $391M | $243M | $253M | $214M | |
| PP&E (Net) | $141M | $167M | $174M | $184M | $188M | $137M | $105M | $109M | $107M | $101M | $90M | $61M | |
| PP&E (Gross) | $278M | $300M | $309M | $301M | $274M | $215M | $180M | $170M | $156M | $139M | $115M | $81M | |
| Accum. Depreciation | $138M | $133M | $135M | $117M | $85M | $78M | $75M | $62M | $49M | $38M | $25M | $20M | |
| Goodwill | $20M | $0 | $163M | $163M | $145M | $100M | $100M | $62M | $55M | $47M | $31M | $24M | |
| Intangibles | $368M | $426M | $483M | $541M | $624M | $97M | $104M | $0 | · | $0 | $81.0K | $403.0K | |
| Other Non-current Assets | · | · | · | · | · | · | · | $657.0K | $825.0K | $624.0K | $406.0K | $3M | |
| Total Assets | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Accounts Payable | $15M | $19M | $16M | $15M | $11M | $10M | $13M | $14M | $15M | $8M | $9M | $7M | |
| Accrued Liabilities | $96M | $80M | $64M | $90M | $128M | $71M | $70M | $46M | $41M | $37M | $35M | $28M | |
| Current Liabilities | $121M | $310M | $97M | $148M | $521M | $253M | $108M | $61M | $56M | $45M | $150M | $140M | |
| Capital Leases | $36M | $45M | $55M | $65M | $72M | $71M | $41M | $0 | · | · | · | · | |
| Deferred Tax | $4M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $21M | $17M | $14M | $10M | $20M | $4M | $2M | $17M | $16M | $19M | $11M | $5M | |
| Total Liabilities | $572M | $775M | $704M | $906M | $1.34B | $655M | $476M | $368M | $349M | $172M | $169M | $155M | |
| Long-term Debt | $372M | $585M | $522M | $689M | · | · | · | · | · | $109M | $104M | $103M | |
| Total Debt | $372M | · | · | · | · | · | · | · | · | $119M | $119M | $120M | |
| Common Stock | $48.0K | $47.0K | $46.0K | $46.0K | $45.0K | $44.0K | $42.0K | $41.0K | $41.0K | $37.0K | $37.0K | $36.0K | |
| Paid-in Capital | $1.06B | $1.01B | $977M | $924M | $942M | $873M | $754M | $710M | $669M | $565M | $527M | $481M | |
| Retained Earnings | $-199M | $-206M | $-107M | $-149M | $-212M | $-254M | $-399M | $-388M | $-389M | $-346M | $-308M | $-310M | |
| Treasury Stock | $177M | $25M | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $4M | $343.0K | $247.0K | $-380.0K | $167.0K | $318.0K | $322.0K | $-280.0K | $-454.0K | $-30.0K | $-52.0K | $-80.0K | |
| Stockholders' Equity | $693M | $778M | $870M | $775M | $730M | $620M | $355M | $321M | $279M | $219M | $218M | $171M | |
| Liabilities + Equity | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831M | $689M | $628M | $391M | $388M | $326M | |
| Shares Outstanding | 41,116,739 | 47,078,000 | 46,481,000 | 45,928,000 | 44,734,000 | 43,637,000 | 41,908,148 | 41,222,799 | 40,668,877 | 37,480,952 | 36,848,319 | 36,150,620 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $91M | $79M | $76M | $92M | $29M | $20M | $20M | $13M | $14M | $13M | $11M | $10M | |
| Stock-based Comp | $58M | $51M | $48M | $48M | $42M | $40M | $34M | $32M | $32M | $31M | $33M | $25M | |
| Deferred Tax | $6M | $21M | $16M | $-8M | $11M | $-127M | $-2M | $0 | $0 | · | · | · | |
| Amort. of Intangibles | $57M | $57M | $57M | $57M | $14M | $8M | $6M | $0 | $0 | $100.0K | $300.0K | $800.0K | |
| Restructuring | $4M | $9M | $1M | $0 | $0 | $-38.0K | $847.0K | $2M | · | · | · | · | |
| Other Non-cash | $-10M | $138M | $-26M | $-2M | $2M | $-2M | $30M | $4M | $15M | $27M | $-18M | $4M | |
| Operating Cash Flow | $152M | $189M | $155M | $145M | $126M | $77M | $71M | $49M | $18M | $33M | $28M | $27M | |
| CapEx | $15M | $11M | $15M | $30M | $46M | $38M | $10M | $15M | $19M | $25M | $40M | $23M | |
| Investing Cash Flow | $99M | $-83M | $78M | $-225M | $-21M | $-278M | $-128M | $21M | $-224M | · | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-4.0K | $-1M | · | |
| Stock Repurchased | $148M | $25M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-148M | $-25M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-370M | $17M | $-183M | $-402M | $381M | $222M | $4M | $9M | $224M | · | · | · | |
| Net Change in Cash | $-118M | $123M | $49M | $-481M | $486M | $22M | $-54M | $78M | · | · | · | · | |
| Taxes Paid | $9M | $11M | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $137M | $179M | $139M | $115M | $80M | $39M | $60M | $34M | $-1M | $9M | $-12M | $4M | |
| Levered FCF | · | · | $126M | $67M | $56M | $-147M | $36M | $10M | $-20M | $2M | $-19M | $-5M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.6% | · | 13.0% | 9.0% | 16.6% | 10.8% | 2.5% | 4.7% | -8.7% | -11.6% | 3.8% | -2.6% | |
| Net Margin | 0.97% | · | 6.2% | 2.4% | 7.8% | 33.9% | -2.6% | -0.14% | -14.9% | -13.7% | 0.75% | -6.9% | |
| Pretax Margin | 2.3% | · | 9.1% | 2.0% | 10.4% | 4.7% | -2.5% | -0.13% | -14.8% | -13.7% | 0.85% | -6.9% | |
| EBITDA Margin | 15.2% | · | 24.2% | 22.7% | 21.9% | 15.4% | 7.1% | 8.6% | -3.9% | -6.9% | 8.4% | 2.5% | |
| ROA | 0.50% | -6.4% | 2.6% | 0.85% | 2.5% | 13.8% | -1.5% | -0.07% | -8.4% | -9.7% | 0.52% | -5.5% | |
| ROE | 0.97% | -13.0% | 4.9% | 2.1% | 5.8% | 24.2% | -3.1% | -0.15% | -17.1% | -17.3% | 0.95% | -12.9% | |
| ROIC | 0.75% | -14.9% | 6.9% | 9.3% | 9.2% | 54.2% | 3.0% | 5.5% | -8.9% | -9.5% | 2.5% | -1.8% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 | 2.6 | 3.8 | 7.9 | 7.0 | 5.4 | 1.7 | 1.5 | |
| Quick Ratio | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 | 2.3 | 3.2 | 6.9 | 6.1 | 4.5 | 1.2 | 1.3 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | 0.5 | 0.5 | 0.7 | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 4.3 | 1.5 | 2.8 | 1.8 | 0.4 | 0.7 | -1.4 | -4.5 | 1.2 | -0.6 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | 0.8 | |
| Inventory Turnover | 1.1 | 1.5 | 1.8 | 2.0 | 1.7 | 1.9 | 2.0 | 1.9 | 2.4 | 2.4 | 1.6 | 3.5 | |
| Receivables Turnover | 6.1 | · | 6.6 | 6.8 | 7.3 | 8.5 | 9.8 | 9.7 | 9.3 | 9.9 | 10.3 | 10.7 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.86 | $16.83 | $18.72 | $16.87 | $16.33 | $14.20 | $8.47 | $7.79 | $6.87 | $5.84 | $5.93 | $4.73 | |
| Revenue / Share | $16.13 | · | $12.99 | $14.33 | $11.87 | $9.84 | $10.14 | · | $7.20 | $7.42 | $6.03 | · | |
| Cash Flow / Share | $3.37 | $4.10 | $2.98 | $3.12 | $2.76 | $1.76 | $1.70 | · | $0.45 | $0.90 | $0.70 | · | |
| Cash / Share | $3.86 | $5.99 | $3.30 | $2.27 | $13.09 | $2.29 | $1.87 | $3.21 | $1.33 | $0.96 | $1.55 | $1.04 | |
| EPS (TTM) | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 | $3.33 | $-0.27 | $-0.01 | $-1.07 | $-1.02 | $0.04 | $-0.39 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.6% | 3.9% | 1.2% | 23.1% | 26.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 2.9% | 9.0% | 16.2% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | 161.8% | -63.0% | -72.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -22.2% | · | -35.6% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -45.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | 163.7% | -62.1% | -71.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -23.8% | · | -33.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -45.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $726M | $701M | $675M | $667M | $542M | $430M | $421M | $337M | $287M | $276M | $249M | $198M | |
| Net Income TTM | $7M | $-100M | $42M | $16M | $42M | $146M | $-11M | $-471.0K | $-43M | $-38M | $2M | $-14M | |
| Market Cap | $1.06B | $871M | $1.57B | $1.77B | $2.69B | $2.61B | $1.90B | $1.77B | $1.86B | $1.21B | $2.83B | $3.21B | |
| Enterprise Value | $1.20B | · | · | · | · | · | · | · | · | $1.16B | $2.79B | $3.17B | |
| P/E | 161.8 | -8.8 | 37.9 | 113.6 | 65.4 | 18.0 | -167.8 | -4302.0 | -42.7 | -31.7 | 1919.8 | -227.3 | |
| P/S | 1.5 | 1.2 | 2.3 | 2.7 | 5.0 | 6.1 | 4.5 | 5.3 | 6.5 | 4.4 | 11.4 | 16.2 | |
| P/B | 1.5 | 1.1 | 1.8 | 2.3 | 3.7 | 4.2 | 5.3 | 5.5 | 6.6 | 5.5 | 13.0 | 18.7 | |
| P / Tangible Book | 3.5 | 2.5 | 7.0 | 24.9 | · | 6.2 | · | · | · | · | · | · | |
| P / Cash Flow | 7.0 | 4.6 | 10.1 | 12.2 | 21.4 | 33.9 | 26.9 | 36.3 | 104.4 | 36.2 | 97.6 | 125.8 | |
| P / FCF | 7.8 | 4.9 | 11.2 | 15.4 | 33.7 | 66.6 | 31.5 | 51.6 | -1253.6 | 138.5 | -230.5 | 895.3 | |
| EV / EBITDA | 10.9 | · | · | · | · | · | · | · | · | -60.5 | 133.3 | 650.6 | |
| EV / FCF | 8.8 | · | · | · | · | · | · | · | · | 132.3 | -227.2 | 885.0 | |
| EV / Revenue | 1.6 | · | · | · | · | · | · | · | · | 4.2 | 11.2 | 16.0 | |
| Earnings Yield | 0.62% | -11.4% | 2.6% | 0.88% | 1.5% | 5.6% | -0.60% | -0.02% | -2.3% | -3.2% | 0.05% | -0.44% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192M | $177M | $197M | $180M | $181M | $169M | $187M | $169M | $178M | $167M | $181M | $164M | $169M | $160M | · | $167M | |
| Cost of Revenue | $44M | $36M | $40M | $34M | $41M | $34M | $40M | $39M | $44M | $47M | $48M | $40M | $48M | $49M | $62M | $51M | |
| R&D Expense | $30M | $28M | $38M | $26M | $28M | $25M | $24M | $19M | $20M | $18M | $19M | $21M | $19M | $17M | $18M | $19M | |
| SG&A Expense | $92M | $94M | $102M | $92M | $89M | $87M | $80M | $74M | $68M | $72M | $66M | $68M | $65M | $71M | $64M | $61M | |
| Operating Expenses | $188M | $170M | $195M | $173M | $173M | $167M | $163M | $308M | $150M | $154M | $148M | $146M | $130M | $163M | · | $146M | |
| Operating Income | $4M | $7M | $2M | $6M | $8M | $2M | $25M | $-140M | $28M | $13M | $33M | $18M | $40M | $-3M | $-10M | $21M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $4M | $10M | · | $10M | |
| Interest Income | $2M | $2M | $2M | $9M | $5M | $7M | $6M | $5M | $5M | $4M | $3M | $3M | $2M | $3M | $3M | $1M | |
| Other Non-op | $-34.0K | $-135.0K | $-172.0K | $-110.0K | $-11M | $4M | $-53.0K | $-122.0K | $-39.0K | $-159.0K | $515.0K | $-422.0K | $-269.0K | $-10.0K | $81.0K | $-11M | |
| Pretax Income | $3M | $5M | $571.0K | $10M | $-2M | $9M | $26M | $-139M | $37M | $14M | $34M | $17M | $38M | $-26M | $-18M | $2M | |
| Income Tax | $-2M | $2M | $-1M | $4M | $3M | $4M | $9M | $5M | $18M | $5M | $9M | $6M | $12M | $-7M | $-8M | $3M | |
| Net Income | $5M | $3M | $2M | $5M | $-5M | $5M | $16M | $-143M | $19M | $9M | $25M | $11M | $26M | $-20M | $-10M | $-693.0K | |
| EPS (Basic) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.36 | $-3.11 | $0.41 | $0.19 | $0.55 | $0.23 | $0.56 | $-0.43 | $-0.22 | $-0.02 | |
| EPS (Diluted) | $0.12 | $0.07 | $0.05 | $0.12 | $-0.11 | $0.10 | $0.38 | $-3.11 | $0.39 | $0.19 | $0.58 | $0.23 | $0.51 | $-0.43 | $-0.19 | $-0.02 | |
| Shares (Basic) | 39,462,000 | 40,461,000 | · | 44,038,000 | 45,459,000 | 46,275,000 | · | 46,134,000 | 46,174,000 | 46,499,000 | · | 46,416,000 | 46,088,000 | 45,949,000 | · | 45,831,000 | |
| Shares (Diluted) | 40,300,000 | 40,910,000 | · | 44,459,000 | 45,459,000 | 46,526,000 | · | 46,134,000 | 50,539,000 | 52,193,000 | · | 52,067,000 | 52,054,000 | 45,949,000 | · | 45,831,000 | |
| EBITDA | $4M | $28M | · | $6M | $8M | $23M | · | $-140M | $28M | $32M | · | $18M | $40M | $17M | · | $21M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $206M | $144M | $159M | $148M | $300M | $284M | $277M | $246M | $247M | $184M | · | $99M | $87M | $36M | · | $109M | |
| Short-term Investments | $45M | $58M | $80M | $99M | $145M | $210M | $208M | $208M | $157M | $142M | · | $136M | $134M | $138M | · | $219M | |
| Receivables | $132M | $126M | $124M | $115M | $114M | $105M | $113M | $101M | $105M | $102M | · | $97M | $99M | $93M | · | $93M | |
| Inventory | $135M | $150M | $153M | $158M | $148M | $134M | $125M | $112M | $103M | $97M | · | $97M | $92M | $93M | · | $97M | |
| Prepaid Expense | $30M | $37M | $33M | $43M | $37M | $28M | $22M | $24M | $20M | $19M | · | $19M | $17M | $16M | · | $14M | |
| Current Assets | $615M | $515M | $548M | $563M | $746M | $760M | $745M | $690M | $632M | $543M | · | $447M | $429M | $376M | · | $533M | |
| PP&E (Net) | $130M | $136M | $141M | $147M | $155M | $164M | $167M | $167M | $169M | $172M | · | $176M | $180M | $182M | · | $194M | |
| PP&E (Gross) | $281M | $281M | $278M | $280M | $308M | $304M | $300M | $297M | $293M | $292M | · | $307M | $308M | $305M | · | $295M | |
| Accum. Depreciation | $151M | $145M | $138M | $133M | $153M | $140M | $133M | $130M | $124M | $120M | · | $131M | $128M | $123M | · | $102M | |
| Goodwill | $20M | $20M | $20M | $20M | $20M | $22M | $0 | $0 | $163M | $163M | $163M | $163M | $163M | $163M | · | $157M | |
| Intangibles | $285M | $353M | $368M | $382M | $423M | $435M | $426M | $440M | $455M | $469M | · | $498M | $512M | $526M | · | $581M | |
| Total Assets | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Accounts Payable | $18M | $14M | $15M | $18M | $30M | $23M | $19M | $19M | $19M | $9M | · | $17M | $24M | $17M | · | $13M | |
| Accrued Liabilities | $93M | $85M | $96M | $80M | $71M | $80M | $80M | $76M | $65M | $67M | · | $60M | $56M | $62M | · | $76M | |
| Current Liabilities | $122M | $109M | $121M | $107M | $313M | $315M | $310M | $306M | $93M | $93M | · | $94M | $109M | $99M | · | $132M | |
| Capital Leases | $39M | $34M | $36M | $39M | $41M | $44M | $45M | $48M | $50M | $52M | · | $57M | $60M | $62M | · | $65M | |
| Deferred Tax | $4M | $4M | $4M | $5M | $5M | $7M | $0 | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $27M | $25M | $21M | $25M | $25M | $24M | $17M | $13M | $13M | $13M | · | $12M | $12M | $12M | · | $19M | |
| Total Liabilities | $572M | $555M | $572M | $570M | $779M | $788M | $775M | $772M | $768M | $691M | · | $703M | $734M | $755M | · | $964M | |
| Long-term Debt | $363M | $368M | $372M | $377M | $580M | $583M | $585M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $363M | $368M | · | $377M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $49.0K | $48.0K | $48.0K | $48.0K | $48.0K | $47.0K | $47.0K | $47.0K | $47.0K | $47.0K | · | $46.0K | $46.0K | $46.0K | · | $46.0K | |
| Paid-in Capital | $1.09B | $1.07B | $1.06B | $1.05B | $1.04B | $1.02B | $1.01B | $996M | $983M | $990M | · | $963M | $951M | $936M | · | $909M | |
| Retained Earnings | $-192M | $-196M | $-199M | $-201M | $-206M | $-202M | $-206M | $-222M | $-79M | $-98M | · | $-132M | $-143M | $-168M | · | $-139M | |
| Treasury Stock | $227M | $227M | $177M | $126M | $76M | $25M | $25M | $25M | $25M | · | · | · | · | · | · | · | |
| AOCI | $3M | $3M | $4M | $4M | $4M | $1M | $343.0K | $678.0K | $105.0K | $152.0K | · | $-10.0K | $-173.0K | $-137.0K | · | $-670.0K | |
| Stockholders' Equity | $672M | $654M | $693M | $727M | $758M | $799M | $778M | $750M | $879M | $892M | $870M | $832M | $808M | $768M | $775M | $770M | |
| Liabilities + Equity | $1.24B | $1.21B | $1.26B | $1.30B | $1.54B | $1.59B | $1.55B | $1.52B | $1.65B | $1.58B | · | $1.53B | $1.54B | $1.52B | · | $1.73B | |
| Shares Outstanding | 39,822,298 | 39,309,610 | 41,116,739 | 42,965,902 | 44,897,766 | 46,283,407 | 46,240,604 | 46,148,146 | 46,117,359 | 46,517,410 | 46,481,000 | 46,426,836 | 46,408,961 | 45,970,340 | 45,928,000 | 45,864,319 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21M | $21M | $21M | $21M | $27M | $21M | $21M | $20M | $19M | $18M | $18M | $18M | $19M | $20M | $30M | $20M | |
| Stock-based Comp | $15M | $14M | $13M | $14M | $15M | $15M | $12M | $13M | $13M | $13M | $12M | $13M | $11M | $12M | $13M | $13M | |
| Deferred Tax | · | · | $-4M | $8M | $752.0K | $1M | $4M | $1M | $13M | $3M | $7M | $5M | $11M | $-7M | $-11M | $702.0K | |
| Amort. of Intangibles | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Restructuring | · | · | $-54.0K | $4M | $0 | $0 | $808.0K | $1M | $996.0K | $6M | $0 | $173.0K | $936.0K | · | $0 | $0 | |
| Other Non-cash | · | $-12M | · | · | · | $-6M | · | · | · | $5M | · | · | · | $14M | · | · | |
| Operating Cash Flow | $57M | $26M | $44M | $61M | $12M | $35M | $33M | $54M | $53M | $49M | $48M | $44M | $43M | $19M | $42M | $43M | |
| CapEx | $1M | $3M | $218.0K | $4M | $3M | $9M | $2M | $4M | $2M | $3M | $2M | $3M | $3M | $7M | $5M | $5M | |
| Investing Cash Flow | $12M | $19M | $19M | $44M | $62M | $-26M | $-368.0K | $-52M | $-15M | $-16M | $8M | $-4M | $7M | $66M | $11M | $-48M | |
| Stock Repurchased | $0 | $50M | $48M | $50M | $50M | $0 | $0 | $0 | · | · | $0 | $0 | · | · | · | · | |
| Net Stock Activity | · | $-50M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-8M | $-59M | $-52M | $-257M | $-58M | $-3M | $-2M | $-3M | $25M | $-3M | $-2M | $-28M | $440.0K | $-154M | $-59M | $-8M | |
| Net Change in Cash | $62M | $-14M | $11M | $-153M | $17M | $7M | $31M | $-1M | $63M | $31M | $54M | $12M | $51M | $-69M | $-5M | $-13M | |
| Taxes Paid | $860.0K | $50.0K | $69.0K | $711.0K | $8M | $286.0K | $1M | $5M | $5M | $-245.0K | $2M | $1M | $594.0K | $201.0K | · | $112.0K | |
| Free Cash Flow | · | $23M | · | · | · | $27M | · | · | · | $46M | · | · | · | $13M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $44M | · | · | · | $5M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.2% | 3.9% | · | 3.5% | 4.7% | 1.2% | · | -82.8% | 15.9% | 7.9% | · | 10.8% | 23.5% | -1.9% | · | 12.7% | |
| Net Margin | 2.4% | 1.6% | · | 3.0% | -2.7% | 2.9% | · | -85.1% | 10.6% | 5.4% | · | 6.6% | 15.2% | -12.2% | · | -0.41% | |
| Pretax Margin | 1.3% | 2.8% | · | 5.3% | -1.1% | 5.1% | · | -82.4% | 20.5% | 8.2% | · | 10.1% | 22.3% | -16.5% | · | 1.2% | |
| EBITDA Margin | 2.2% | 15.9% | · | 3.5% | 4.7% | 13.7% | · | -82.8% | 15.9% | 18.9% | · | 10.8% | 23.5% | 10.3% | · | 12.7% | |
| ROA | 0.33% | 0.21% | · | 0.39% | -0.30% | 0.30% | · | -9.4% | 1.2% | 0.58% | · | 0.66% | 1.6% | -1.1% | · | -0.04% | |
| ROE | 0.65% | 0.40% | · | 0.74% | -0.59% | 0.57% | · | -18.1% | 2.2% | 1.1% | · | 1.4% | 3.3% | -2.6% | · | -0.09% | |
| ROIC | 0.75% | 0.39% | · | 0.33% | 2.8% | 0.14% | · | -19.2% | 1.7% | 0.97% | · | 1.4% | 3.4% | -0.30% | · | -0.93% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 4.7 | · | 5.3 | 2.4 | 2.4 | · | 2.3 | 6.8 | 5.8 | · | 4.8 | 3.9 | 3.8 | · | 4.1 | |
| Quick Ratio | 3.1 | 3.0 | · | 3.4 | 1.8 | 1.9 | · | 1.8 | 5.5 | 4.6 | · | 3.5 | 2.9 | 2.7 | · | 3.2 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.6 | · | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 4.0 | · | 5.1 | 10.3 | -0.3 | · | 2.2 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.5 | · | 0.6 | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.7 | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.7 | · | 1.7 | 1.8 | 1.7 | · | 2.3 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $16.87 | $16.63 | · | $16.93 | $16.88 | $17.25 | · | $16.24 | $19.07 | $19.18 | · | $17.91 | $17.41 | $16.71 | · | $16.79 | |
| Revenue / Share | $4.77 | $4.34 | · | $4.04 | $3.98 | $3.63 | · | $3.65 | $3.52 | $3.20 | · | $3.15 | $3.26 | $3.49 | · | $3.65 | |
| Cash Flow / Share | · | $0.63 | · | · | · | $0.76 | · | · | · | $0.94 | · | · | · | $0.42 | · | · | |
| Cash / Share | $5.17 | $3.67 | · | $3.44 | $6.69 | $6.13 | · | $5.33 | $5.36 | $3.96 | · | $2.13 | $1.87 | $0.77 | · | $2.39 | |
| EPS (TTM) | $0.36 | $0.13 | · | $0.49 | $-2.74 | $-2.24 | · | $-1.95 | $1.39 | $1.51 | · | $0.12 | $-0.13 | $-0.24 | · | $0.41 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $746M | $735M | · | $717M | $706M | $703M | · | $695M | $690M | $682M | · | · | · | · | · | $654M | |
| Net Income TTM | $15M | $5M | · | $21M | $-127M | $-104M | · | $-91M | $64M | $70M | · | $7M | $-5M | $-10M | · | $21M | |
| Market Cap | $1.01B | $888M | · | $1.11B | $1.07B | $1.15B | · | $695M | $1.32B | $1.36B | · | $1.42B | $1.86B | $1.88B | · | $2.44B | |
| Enterprise Value | $1.12B | $1.05B | · | $1.24B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 70.5 | 173.8 | · | 52.6 | -8.7 | -11.1 | · | -7.7 | 20.6 | 19.4 | · | 255.7 | -308.2 | -170.0 | · | 129.7 | |
| P/S | 1.4 | 1.2 | · | 1.5 | 1.5 | 1.6 | · | 1.0 | 1.9 | 2.0 | · | · | · | · | · | 3.7 | |
| P/B | 1.5 | 1.4 | · | 1.5 | 1.4 | 1.4 | · | 0.9 | 1.5 | 1.5 | · | 1.7 | 2.3 | 2.4 | · | 3.2 | |
| P / Tangible Book | 2.8 | 3.2 | · | 3.4 | 3.4 | 3.4 | · | 2.2 | 5.0 | 5.2 | · | 8.3 | 14.0 | 23.9 | · | 76.8 | |
| P / Cash Flow | · | 34.6 | · | · | · | 32.4 | · | · | · | 27.7 | · | · | · | 98.1 | · | · | |
| EV / Revenue | 1.5 | 1.4 | · | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 1.4% | 0.58% | · | 1.9% | -11.5% | -9.0% | · | -13.0% | 4.9% | 5.2% | · | 0.39% | -0.32% | -0.59% | · | 0.77% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $726M | $701M | $675M | $667M | $542M |
| Margin Operasi % | 2.6% | · | 13.0% | 9.0% | 16.6% |
| Laba Bersih | $7M | $-100M | $42M | $16M | $42M |
| EPS Dilusian | $0.16 | $-2.15 | $0.89 | $0.34 | $0.92 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.5 | · | · | · | · |
| Rasio Lancar | 4.5 | 2.4 | 5.2 | 3.4 | 1.7 |
| Rasio Cepat | 3.0 | 1.9 | 3.9 | 2.6 | 1.4 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $137M | $179M | $139M | $115M | $80M |
Pemilik institusional (13F) 266 pengaju · $1.2B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
266
Nilai yang dipegang
$1.2B
Posisi baru
36
Posisi yang keluar
23
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 36 (0 vs Kuartal sebelumnya) | 23 (-16 vs Kuartal sebelumnya) | 79 (-8 vs Kuartal sebelumnya) | 85 (+5 vs Kuartal sebelumnya) | +308K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BlackRock, Inc. | $170.126.377 | 6.705.809 | 14,10% | Saham |
| VANGUARD GROUP INC | $124.559.276 | 4.812.955 | 10,32% | Saham |
| Doma Perpetual Capital Management LLC | $70.472.634 | 2.777.794 | 5,84% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $61.046.258 | 2.406.238 | 5,06% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $53.360.107 | 2.103.245 | 4,42% | Saham |
| STATE STREET CORP | $52.261.616 | 2.059.977 | 4,33% | Saham |
| D. E. Shaw & Co., Inc. | $49.479.923 | 1.950.332 | 4,10% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $43.986.531 | 1.733.801 | 3,65% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $42.915.156 | 1.691.571 | 3,56% | Saham |
| GOLDMAN SACHS GROUP INC | $38.743.263 | 1.527.129 | 3,21% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $29.401.072 | 1.158.693 | 2,44% | Saham |
| MORGAN STANLEY | $29.039.913 | 1.144.654 | 2,41% | Saham |
| AMERICAN CENTURY COMPANIES INC | $25.829.019 | 1.018.093 | 2,14% | Saham |
| UBS Group AG | $23.345.905 | 920.217 | 1,94% | Saham |
| Impax Asset Management Group plc | $19.028.185 | 750.027 | 1,58% | Saham |
| TWO SIGMA INVESTMENTS, LP | $18.383.203 | 724.604 | 1,52% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17.525.241 | 690.786 | 1,45% | Saham |
| GAGNON SECURITIES LLC | $15.440.613 | 608.617 | 1,28% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $14.294.929 | 563.458 | 1,18% | Saham |
| NORTHERN TRUST CORP | $13.364.459 | 526.782 | 1,11% | Saham |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $10.436.533 | 411.373 | 0,87% | Saham |
| DEUTSCHE BANK AG\ | $9.922.232 | 391.101 | 0,82% | Saham |
| Jefferies Financial Group Inc. | $9.389.234 | 370.092 | 0,78% | Saham |
| Hillsdale Investment Management Inc. | $9.201.699 | 362.700 | 0,76% | Saham |
| Gagnon Advisors, LLC | $8.946.401 | 352.637 | 0,74% | Saham |
| JPMORGAN CHASE & CO | $8.698.627 | 346.697 | 0,72% | Saham |
| EASTERLY INVESTMENT PARTNERS LLC | $8.550.172 | 337.019 | 0,71% | Saham |
| Bridge City Capital, LLC | $7.922.975 | 312.297 | 0,66% | Saham |
| BARCLAYS PLC | $7.869.496 | 310.189 | 0,65% | Saham |
| Bank of New York Mellon Corp | $7.531.837 | 296.880 | 0,62% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $7.129.402 | 281.017 | 0,59% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $6.633.164 | 261.457 | 0,55% | Saham |
| Invesco Ltd. | $6.326.010 | 249.350 | 0,52% | Saham |
| BANK OF AMERICA CORP /DE/ | $6.088.952 | 240.006 | 0,50% | Saham |
| MILLENNIUM MANAGEMENT LLC | $5.966.085 | 235.163 | 0,49% | Saham |
| Coppell Advisory Solutions LLC | $5.592.970 | 16 | 0,46% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $5.562.474 | 219.254 | 0,46% | Saham |
| FMR LLC | $5.505.316 | 217.001 | 0,46% | Saham |
| Empowered Funds, LLC | $5.075.852 | 200.073 | 0,42% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $5.068.926 | 199.800 | 0,42% | Saham |
| ROYAL BANK OF CANADA | $4.704.000 | 185.433 | 0,39% | Saham |
| Banco Santander, S.A. | $4.211.420 | 166.000 | 0,35% | Saham |
| Robeco Institutional Asset Management B.V. | $4.161.036 | 164.014 | 0,34% | Saham |
| AMERIPRISE FINANCIAL INC | $4.137.744 | 163.096 | 0,34% | Saham |
| CITADEL ADVISORS LLC | $4.114.101 | 162.164 | 0,34% | Saham |
| AQR CAPITAL MANAGEMENT LLC | $4.021.427 | 158.511 | 0,33% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.562.811 | 140.434 | 0,30% | Saham |
| Public Sector Pension Investment Board | $3.429.720 | 135.188 | 0,28% | Saham |
| PDT Partners, LLC | $3.358.176 | 132.368 | 0,28% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.292.062 | 129.762 | 0,27% | Saham |
Aktivis & pemilik 5%+ 16 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC, DOMA1 LLC, DOMA Perpetual LO Equity Master Fund LP, DOMA Perpetual Partners GP LLC, Pedro Escudero, The John Templeton Foundation, DOMA2 LLC, Eric de Armas ×4 pengajuan | 12 Maret 2026 | 7,30% | Amandemen | Kampanye dewan | SEC |
| Consonance Capital Management LP, Consonance Capman GP LLC, Mitchell Blutt ×5 pengajuan | 6 Sep. 2019 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 18 Maret 2014 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 26 Juli 2013 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 2 April 2013 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 21 Maret 2013 | · | Pengajuan awal | · | SEC |
| Sanderling Venture Partners VI, L.P., Sanderling Ventures Management VI, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling VI Limited Partnership, Sanderling Venture Partners VI Co-Investment Fund, L.P., Middleton, McNeil, Mills & Associates VI, LLC, Fred A. Middleton ×4 pengajuan | 21 Maret 2013 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 28 Sep. 2012 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 15 Juni 2012 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 19 Maret 2012 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 1 Des. 2011 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 1 Des. 2011 | · | Pengajuan awal | Investasi pasif | SEC |
| MPM BioVentures IV-QP, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, Todd Foley, James Paul Scopa, Vaughn M. Kailian, John Vander Vort | 29 Nov. 2011 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 18 Feb. 2011 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 18 Feb. 2011 | · | Pengajuan awal | · | SEC |
| MPM BioVentures IV Q-P, L.P., MPM BioVentures IV GmbH & Co. Beteiligungs KG, MPM Asset Management Investors BV4 LLC, MPM BioVentures IV GP LLC, MPM BioVentures IV LLC, Ansbert Gadicke, Luke Evnin, Steven St. Peter, William Greene, James Paul Scopa, Ashley Dombkowski, Vaughn M. Kailian, John Vander Vort | 18 Feb. 2011 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 44 orang dalam · 20 pejabat · 17 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Frank D. Lee | Chief Executive Officer | 11 Feb. 2026 A | 660.831 | 0 | 0 | $0 |
| David M Stack | CEO and Chairman | 14 Juni 2023 A | 186.481 | 0 | 0 | $0 |
| Shawn Cross | Chief Financial Officer | 23 April 2026 M | 105.341 | 0 | 7 | $-1.521.351 |
| Max Reinhardt | President, Rest of World | 7 Juni 2023 S | 29.225 | 0 | 0 | $0 |
| James S Scibetta | President | 5 Juni 2017 S | 25.118 | 0 | 0 | $0 |
| Scott Braunstein | Chief Operating Officer | 3 Jan. 2018 A | 20.982 | 0 | 0 | $0 |
| Jonathan Slonin | Chief Medical Officer | 17 Agu 2026 S | 216.384 | 0 | 3 | $-240.431 |
| Lauren Riker | Senior Vice President, Finance | 11 Juni 2026 S | 62.284 | 0 | 3 | $-261.266 |
| Kristen Williams | Chief Administrative Officer | 4 Juni 2026 S | 167.062 | 0 | 2 | $-498.171 |
| Brendan Teehan | Chief Commercial Officer | 11 Feb. 2026 A | 100.934 | 0 | 0 | $0 |
| Ronald J. Ellis Jr. | Chief Strategy Officer | 7 Juni 2023 S | 30.909 | 0 | 0 | $0 |
| Dennis Mcloughlin | Chief Customer Officer | 7 Juni 2023 S | 38.115 | 0 | 0 | $0 |
| Anthony Molloy | Chief Lgl & Compliance Officer | 6 Juni 2023 S | 12.877 | 0 | 0 | $0 |
| Charles Anthony Laranjeira | Chief Technical Officer | 14 Juni 2022 M | 41.752 | 0 | 0 | $0 |
| Richard Scranton | Chief Scientific Officer | 8 Nov. 2019 M | 16.061 | 0 | 0 | $0 |
| Robert J. Weiland | Chief Commercial Officer | 4 Juni 2018 S | 5.088 | 0 | 0 | $0 |
| James B Jones | SVP & Chief Medical Officer | 20 Nov. 2017 S | 16.823 | 0 | 0 | $0 |
| Taunia Markvicka | SVP, Chief Commercial Officer | 17 Maret 2015 M | 8.579 | 0 | 0 | $0 |
| Gary Patou | Chief Medical Officer | 7 Agu 2014 M | 0 | 0 | 0 | $0 |
| John Pratt | General Manager, San Diego | 13 Juni 2013 M | 0 | 0 | 0 | $0 |
| Marcelo Bigal | Direktur | 10 Juni 2026 A | 17.798 | 0 | 0 | $0 |
| Alethia Young | Direktur | 10 Juni 2026 A | 17.798 | 0 | 0 | $0 |
| Christopher Christie | Direktur | 10 Juni 2026 A | 23.059 | 0 | 0 | $0 |
| Samit Hirawat | Direktur | 10 Juni 2026 A | 6.405 | 0 | 0 | $0 |
| Mark Froimson | Direktur | 10 Juni 2026 A | 26.541 | 0 | 1 | $-10.905 |
| Michael J. Yang | Direktur | 10 Juni 2026 A | 19.798 | 0 | 0 | $0 |
| Laura Brege | Direktur | 10 Juni 2026 A | 30.120 | 0 | 0 | $0 |
| Thomas G Wiggans | Direktur | 10 Juni 2026 A | · | 0 | 0 | $0 |
| Mark A. Kronenfeld | Direktur | 11 Juni 2025 A | 31.065 | 0 | 0 | $0 |
| Yvonne Greenstreet | Direktur | 8 Juni 2022 A | 13.247 | 0 | 0 | $0 |
| John P Longenecker PHD | Direktur | 3 Maret 2022 M | 18.823 | 0 | 0 | $0 |
| Andreas Wicki | Direktur | 15 Maret 2021 S | 451.324 | 0 | 0 | $0 |
| Dennis L Winger | Direktur | 14 Juni 2017 A | 7.490 | 0 | 0 | $0 |
| Fred A Middleton | Direktur | 24 Juni 2013 S | 0 | 0 | 0 | $0 |
| Luke Evnin | Direktur | 12 Juni 2013 A | 0 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | Pemilik 10% | 25 Maret 2013 S | 2.233.993 | 0 | 0 | $0 |
| Abraham Ceesay | · | 4 Sep. 2025 S | 9.039 | 0 | 0 | $0 |
| Daryl Gaugler | · | 31 Des. 2024 A | 115.443 | 0 | 0 | $0 |
| Charles A. Reinhart III | · | 12 Juni 2024 A | 51.867 | 0 | 0 | $0 |
| Paul J Hastings | · | 12 Juni 2024 A | 12.724 | 0 | 0 | $0 |
| Gary W Pace | · | 8 Maret 2024 S | 22.127 | 0 | 0 | $0 |
| Roy Winston | · | 2 Agu 2023 S | 52.440 | 0 | 0 | $0 |
| Donald C. Manning | · | 9 Juni 2021 A | 29.520 | 0 | 0 | $0 |
| GORDON CARL L | · | 8 Feb. 2011 C | 2.828.941 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 58 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,28% | 10.029 NS | 31 Juli 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,74% | 8.394 NS | 31 Juli 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,55% | 37.961 SH | 2 Okt. 2026 | Harian |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 4.607 SH | 2 Okt. 2026 | Harian |
| RZG · Invesco Exchange-Traded Fund Trust | 0,50% | 23.694 SH | 2 Okt. 2026 | Harian |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0,24% | 27.368 SH | 2 Okt. 2026 | Harian |
| SCOW · Pacer Funds Trust | 0,23% | 151 NS | 31 Juli 2026 | N-PORT |
| IHE · iShares Trust | 0,23% | 145.471 SH | 11 Sep. 2026 | Harian |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 39.523 NS | 31 Juli 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,15% | 202.699 NS | 31 Juli 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,13% | 42.794 SH | 19 Agu 2026 | Harian |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 104.986 NS | 31 Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,11% | 30.919 SH | 19 Agu 2026 | Harian |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,11% | 46.835 SH | 19 Agu 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 86.154 SH | 2 Okt. 2026 | Harian |
| DFSV · Dimensional ETF Trust | 0,07% | 231.891 NS | 31 Juli 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,07% | 3.450 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,07% | 2.809 SH | 2 Okt. 2026 | Harian |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,06% | 5.956 SH | 2 Okt. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,06% | 31.734 SH | 19 Agu 2026 | Harian |
| ROSC · Lattice Strategies Trust | 0,05% | 1.241 NS | 31 Juli 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 137.158 SH | 19 Agu 2026 | Harian |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,05% | 36.708 SH | 2 Okt. 2026 | Harian |
| VFQY · VANGUARD WELLINGTON FUND | 0,04% | 7.883 SH | 19 Agu 2026 | Harian |
| DFAT · Dimensional ETF Trust | 0,04% | 204.980 NS | 31 Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 18.945 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,03% | 1.024.328 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 228.207 SH | 19 Agu 2026 | Harian |
| PKW · Invesco Exchange-Traded Fund Trust | 0,03% | 19.806 SH | 2 Okt. 2026 | Harian |
| EBIT · Harbor ETF Trust | 0,02% | 106 NS | 31 Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,02% | 542.974 SH | 19 Agu 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 2.098 SH | 2 Okt. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,02% | 90.095 NS | 31 Juli 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 17.794 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 453.622 SH | 19 Agu 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,01% | 854.717 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 112.735 SH | 19 Agu 2026 | Harian |
| TILT · FlexShares Trust | 0,01% | 7.900 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 2.019 SH | 11 Sep. 2026 | Harian |
| DFAC · Dimensional ETF Trust | 0,01% | 118.628 NS | 31 Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 1.277 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 6.433 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 28.461 SH | 11 Sep. 2026 | Harian |
| DFAU · Dimensional ETF Trust | 0,00% | 9.932 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 69.932 SH | 11 Sep. 2026 | Harian |
| DFUS · Dimensional ETF Trust | 0,00% | 12.671 NS | 31 Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 12.150 SH | 11 Sep. 2026 | Harian |
| DFUV · Dimensional ETF Trust | 0,00% | 866 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.198.792 SH | 19 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.506 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.388 SH | 19 Agu 2026 | Harian |
| IJR · iShares Trust | · | 2.397.496 SH | 10 Sep. 2026 | Harian |
| IJT · iShares Trust | · | 374.609 SH | 9 Sep. 2026 | Harian |
| IWN · iShares Trust | · | 338.098 SH | 11 Sep. 2026 | Harian |
| XJR · iShares Trust | · | 5.453 SH | 31 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 1.678 SH | 11 Sep. 2026 | Harian |
| ISCV · iShares Trust | · | 8.216 SH | 11 Sep. 2026 | Harian |
| SMMV · iShares Trust | · | 12.184 SH | 19 Agu 2026 | Harian |
PCRX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 13 analis
BELI
Target median
$30.00
+19,0%
3 23,1%
Beli Kuat
6 46,2%
Beli
3 23,1%
Tahan
1 7,7%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
9 analis · 2026-10-01Target rata-rata $30.00 +19,0%
Sekarang
Harga saat ini $25.21
Rendah$23.00
Rata-rata$30.00
Tinggi$38.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| YARW | · | · | · | · | · | · |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| SPTX | · | · | · | · | · | · |
| ANRO | $568M | -8.1 | · | · | -46.1% | · |
| ALMS | · | -3.4 | · | -1011.8% | -61.9% | · |
| APMD | · | · | · | · | · | · |
| SGP | · | · | · | · | 50.0% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 4, 2026